THE ECONOMIC COSTS OF NIDDM

被引:38
作者
SONGER, TJ
机构
[1] Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania
来源
DIABETES-METABOLISM REVIEWS | 1992年 / 8卷 / 04期
关键词
D O I
10.1002/dmr.5610080406
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:389 / 404
页数:16
相关论文
共 86 条
[51]  
(1992)
[52]  
Standards of Medical Fitness, (1987)
[53]  
Drummond MF, Stoddart GL, Principles of economic evaluation of health programs, World Health Stat Q, 38, pp. 355-376, (1985)
[54]  
Weisbrod BA, Economic approaches to evaluating a new medical technology, the drug cimetidine, Economic and Medical Evaluation of Health Care Technologies, pp. 188-206, (1983)
[55]  
Emery DD, Schneiderman LJ, pp. 8-13, (1989)
[56]  
Torrance GW, Measurement of health state utilities for economic appraisal, a review, J Health Economics, 5, pp. 1-30, (1986)
[57]  
Thompson MS, Read JL, Laing M, Feasibility of willingness‐to‐pay measurement in chronic arthritis, Med Decision Making, 4, pp. 195-215, (1984)
[58]  
Lubeck DP, Yelin EH, A question of value: measuring the impact of chronic disease, The Millbank Quarterly, 66, pp. 444-464, (1988)
[59]  
Drummond M, Teeling-Smith G, Wells N, Economic Evaluation in the Development of Medicines, (1988)
[60]  
Torrance GW, Utility approach to measuring health‐related quality of life, J Chron Dis, 40, pp. 593-600, (1987)